Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

706 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial.
Bauer A, Schreinlechner M, Sappler N, Dolejsi T, Tilg H, Aulinger BA, Weiss G, Bellmann-Weiler R, Adolf C, Wolf D, Pirklbauer M, Graziadei I, Gänzer H, von Bary C, May AE, Wöll E, von Scheidt W, Rassaf T, Duerschmied D, Brenner C, Kääb S, Metzler B, Joannidis M, Kain HU, Kaiser N, Schwinger R, Witzenbichler B, Alber H, Straube F, Hartmann N, Achenbach S, von Bergwelt-Baildon M, von Stülpnagel L, Schoenherr S, Forer L, Embacher-Aichhorn S, Mansmann U, Rizas KD, Massberg S; ACEI-COVID investigators. Bauer A, et al. Among authors: brenner c. Lancet Respir Med. 2021 Aug;9(8):863-872. doi: 10.1016/S2213-2600(21)00214-9. Epub 2021 Jun 11. Lancet Respir Med. 2021. PMID: 34126053 Free PMC article. Clinical Trial.
Safety and efficacy of SITAgliptin plus GRanulocyte-colony-stimulating factor in patients suffering from Acute Myocardial Infarction (SITAGRAMI-Trial)--rationale, design and first interim analysis.
Theiss HD, Brenner C, Engelmann MG, Zaruba MM, Huber B, Henschel V, Mansmann U, Wintersperger B, Reiser M, Steinbeck G, Franz WM. Theiss HD, et al. Among authors: brenner c. Int J Cardiol. 2010 Nov 19;145(2):282-284. doi: 10.1016/j.ijcard.2009.09.555. Epub 2010 Jan 3. Int J Cardiol. 2010. PMID: 20051299 Clinical Trial.
FDG-PET reveals improved cardiac regeneration and attenuated adverse remodelling following Sitagliptin + G-CSF therapy after acute myocardial infarction.
Gross L, Paintmayer L, Lehner S, Brandl L, Brenner C, Grabmaier U, Huber B, Bartenstein P, Theiss HD, Franz WM, Massberg S, Todica A, Brunner S. Gross L, et al. Among authors: brenner c. Eur Heart J Cardiovasc Imaging. 2016 Feb;17(2):136-45. doi: 10.1093/ehjci/jev237. Epub 2015 Sep 28. Eur Heart J Cardiovasc Imaging. 2016. PMID: 26420287 Free PMC article.
Sitagliptin plus granulocyte colony-stimulating factor in patients suffering from acute myocardial infarction: A double-blind, randomized placebo-controlled trial of efficacy and safety (SITAGRAMI trial).
Brenner C, Adrion C, Grabmaier U, Theisen D, von Ziegler F, Leber A, Becker A, Sohn HY, Hoffmann E, Mansmann U, Steinbeck G, Franz WM, Theiss HD. Brenner C, et al. Int J Cardiol. 2016 Feb 15;205:23-30. doi: 10.1016/j.ijcard.2015.11.180. Epub 2015 Nov 30. Int J Cardiol. 2016. PMID: 26709136 Clinical Trial.
Combined therapy with sitagliptin plus granulocyte-colony stimulating factor in patients with acute myocardial infarction - Long-term results of the SITAGRAMI trial.
Gross L, Theiss HD, Grabmaier U, Adrion C, Mansmann U, Sohn HY, Hoffmann E, Steinbeck G, Franz WM, Brenner C. Gross L, et al. Among authors: brenner c. Int J Cardiol. 2016 Jul 15;215:441-5. doi: 10.1016/j.ijcard.2016.04.134. Epub 2016 Apr 20. Int J Cardiol. 2016. PMID: 27131268 Clinical Trial.
706 results